Related Experiment Video
Updated: Aug 11, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
Absolute dosimetry for FLASH proton pencil beam scanning radiotherapy
Ana Lourenço1,2, Anna Subiel3, Nigel Lee3
1National Physical Laboratory, Teddington, TW11 0LW, UK. ana.lourenco@npl.co.uk.
Scientific Reports
|February 4, 2023
Summary
Ultra-high dose rate (UHDR) radiation, known as FLASH radiotherapy, spares healthy tissue while effectively treating cancer. Accurate dosimetry for this advanced cancer treatment is now achievable with a new primary standard, ensuring safe clinical trials.
Area of Science:
- Medical Physics
- Oncology
- Radiation Therapy
Background:
- A paradigm shift in clinical oncology is driven by ultra-high dose rate (UHDR) radiation, termed FLASH radiotherapy.
- FLASH radiotherapy shows potential for reduced side effects and improved cancer treatment efficacy compared to conventional dose rates.
- Accurate dosimetry for UHDR is a significant challenge for clinical implementation.
Purpose of the Study:
- To establish accurate dosimetry for FLASH proton beam radiotherapy.
- To develop a primary standard for measuring dose at UHDR.
- To ensure the safe and effective clinical application of FLASH radiotherapy.
Main Methods:
- Measurements using a primary-standard proton calorimeter.
- Derivation of necessary correction factors for absolute dose determination.
- Validation of dosimetry methods for UHDR proton beams.
Main Results:
- Achieved an absolute dose uncertainty of 0.9% (1 sigma) for FLASH proton beam radiotherapy.
- Established a primary standard for FLASH proton radiotherapy dosimetry.
- Demonstrated dosimetry accuracy comparable to conventional radiotherapy treatments.
Conclusions:
- The established primary standard enables accurate and consistent dose delivery for FLASH radiotherapy.
- This dosimetry advancement is crucial for the safe progression of clinical trials involving FLASH radiotherapy.
- Improved dosimetry will facilitate the broader clinical adoption of this innovative cancer treatment modality.

